Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Lumiliximab [USAN:INN]
RN: 357613-86-6
UNII: 8Z13S29R5A

Note

  • A primatized anti-CD23 macaque/human chimeric antibody that inhibits the production of the IgE antibody, for the potential treatment of allergic conditions.

Molecular Formula

  • Unspecified
 

Classification Codes

  • Treatment of Allergic Asthma
  • Treatment of Allergic Asthma, Allergic Rhinitis, and Chronic Lymphocytic Leukemia
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Lumiliximab
  • Lumiliximab [USAN:INN]

Synonyms

  • Gomiliximab
  • Gomiliximab [USAN]
  • IDEC 152
  • IDEC-152
  • Immunoglobulin G1, anti-(human immunoglobulin E receptor type II) (human-Macaca irus monoclonal IDEC-152 gamma1-chain), disulfide with human-Macaca irus monoclonal IDEC-152 kappa-chain, dimer
  • Lumiliximab
  • UNII-8Z13S29R5A

Systematic Name

  • Immunoglobulin G1, anti-(human immunoglobulin E receptor type II) (human-Macaca irus monoclonal IDEC-152 gamma1-chain), disulfide with human-Macaca irus monoclonal IDEC-152 kappa-chain, dimer

Registry Numbers

CAS Registry Number

  • 357613-86-6

FDA UNII

  • 8Z13S29R5A

System Generated Number

  • 0357613866